About
Us

Lisboa 2020
Lisboa 2020
Portugal 2020

Our company

Founded in 1960, Cipan is a company committed to health, and this has been demonstrated in its more than 50-year history

Cipan has developed, either through its own investment or through CDO strategies, three generations of APIs derived from Tetracycline: Tetracycline, Minocycline, Lymecycline, Oxytetracycline, and other third-generation molecules that are currently in commercial phase (CMO) or development (CDO).

Cipan is one of the top 3 companies in producing APIs through fermentation processes, or chemical synthesis processes, which makes it very versatile and the right partner to understand the needs of any client.

Its wide international presence gives Cipan the proven ability to manufacture according to the most demanding standards required by top-level agencies such as the EMA, FDA or CFDA.

In addition, Cipan has its own Registry department which combines knowledge of the entire value chain of the life cycle of a medicine, from its development to the preparation of the regulatory dossier for its commercialization.

Cipan’s competitive edge

  • API PRODUCTION BY FERMENTATION AND ORGANIC SYNTHESIS
  • FDA AND EUROPEAN INSPECTED FACILITIES
  • CONTRACT DEVELOPMENT AND MANUFACTURING CAPABILITIES
  • KNOWLEDGE OF THE API WORLDWIDE MARKET
  • FAST PROTOTYPING OF INDUSTRIAL PROCESSES THROUGH PILOT PLANT FACILITIES

Mission Statement

Our mission is to support our clients by incorporating integrity and quality to the research, development and production of our active pharmaceutical ingredients.

COMPANY HISTORY

Since 2016 Cipan is part of the SUANFARMA group, which is specialized in the development, production & commercialization of ingredients for the pharmaceutical, veterinary & nutritional sectors.

1960

1960


Founded in
Castanheira do Ribatejo

1963

1963


Started Fermentation and
Downstream operations (Tetracyclines)

1965

1965


First FDA
inspection

1969

1969


Started operation of the
first Chemical Synthesis unit

1977

1977


Started operation of the second
Chemical Synthesis unit

1985

1985


Construction of a Chemical Synthesis
for the production of Minocycline HCI

2005

2005


Construction of new
Quality Control and
R&D building

2006

2006


Construction of
the multipurpose plant

2007

2007


Approval of the Certificate of
Suitability to the monograhs of
the European Pharmacopoeia (CEP)
for Minocycline HCI

2012

2012


Approval of the CEP
for Lymecycline

2013

2013


Approval of the CEP
for Tetracycline HCI

2017

2016


Integration into
the SUANFARMA Group

2018

2018


Starting of a New Waste Water
Treatment Plant (2 M€ investment)

2018

2019


Investment in the New Plant
“full automated” state-of-the-art

Products

  • TETRACYCLINE HCI
  • OXYTETRACYCLINE HCI
  • LYMECYCLINE
  • MINOCYCLINE HCI
  • OTHERS
products synthesis

SYNTHESIS

Cipan has comprehensive expertise in the chemistry of Tetracyclines and other complex molecules which endows Cipan with a robust technological platform that can be used to leverage our clients’ projects and hence their competitiveness.

FERMENTATION

Cipan has a deep understanding of biologic processes including downstream processing and purification as well as a comprehensive expertise in a wide range of fermentations using many different types of microorganisms.

products fermentation

News

Certifications
& Awards

CERTIFICATIONS

Cipan has GMP certification for the manufacture of medicines for human and veterinary use and has successfully received inspections from the EMA and FDA that enable it to sell our products in Europe and the USA.

Cipan has recently been approved with the certification of the environmental management system according to the ISO 14001 standard achieved in January 2020 with the recognition by the certifying entity (APCER) that CIPAN has an implemented system that complies with the standard, responding to a requirement expressed in Environmental License.

Contact

Rua da Estação nºs 1 e 1A
2600-726 Castanheira do Ribatejo Portugal

Tlf.: (+351) 263 140 000

Fax: (+351) 263 852 356